Physician profile
Edward F Lin
NPI 1184864621
$2,068.09
in general payments reported to CMS, 2019-2025
10 companies · $271 in 2025
The $271 reported for 2025 was less than what a typical Advanced Heart Failure and Transplant Cardiology provider received nationally (typical 2025 total: $1,046).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $154 · 2020: $20.53 · 2021: $388 · 2022: $139 · 2023: $109 · 2024: $986 · 2025: $271.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $883 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $483.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $883.29 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $483.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $589.91 | 2019-2024 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Analog Devices INC. | $483.23 | 2024 | Sensinel Cpm Wearable |
| Ancora Heart, INC. | $388.00 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $212.09 | 2023-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $148.18 | 2022-2023 | |
| Astrazeneca Pharmaceuticals Lp | $76.43 | 2024-2025 | Wainua, Farxiga |
| Merck Sharp & Dohme LLC | $70.98 | 2024 | Verquvo |
| Bridgebio Pharma, INC. | $58.16 | 2025 | Attruby |
| Lilly USA, LLC | $21.49 | 2024 | |
| Kiniksa Pharmaceuticals International, Plc | $19.62 | 2024 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.